Aberrant overexpression of an epithelial marker, 14-3-3σ, in a subset of hematological malignancies
2007

Overexpression of 14-3-3σ in Blood Cancers

Sample size: 170 publication Evidence: moderate

Author Information

Author(s): Motokura Toru, Nakamura Yukari, Sato Hiroyuki

Primary Institution: Department of Hematology and Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

Hypothesis

The study investigates the expression of 14-3-3σ in hematological malignancies to determine its role in non-epithelial tumors.

Conclusion

14-3-3σ is significantly overexpressed in a subset of mature lymphoid malignancies, indicating its potential involvement in non-epithelial tumors.

Supporting Evidence

  • 14-3-3σ mRNA was overexpressed in 30 of 93 patients with mature lymphoid malignancies.
  • Only 3 of 35 patients with acute leukemia showed increased levels of 14-3-3σ.
  • The expression levels of 14-3-3σ were not correlated with DNA methylation status in hematological malignancies.

Takeaway

This study found that a protein called 14-3-3σ is found in higher amounts in some blood cancers, which is unusual since it's usually linked to skin cancers.

Methodology

The study analyzed 41 hematopoietic cell lines and 129 patient samples using real-time RT-PCR, Western blot analysis, and DNA methylation status assessment.

Potential Biases

Potential bias due to the selection of cell lines and the possibility of normal cells affecting expression levels.

Limitations

The study's findings need confirmation with a larger series of patients to validate the results.

Participant Demographics

129 patients with various hematological malignancies, including chronic lymphocytic leukemia and diffuse large B-cell lymphoma.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-217

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication